BioCentury
ARTICLE | Finance

Sofinnova Partners seeks growth, independence in minority stake sale to Apollo

PE firm commits up to €1B to future funds, while European VC gains access to broader LP base, structured financing instruments

May 16, 2022 12:01 PM UTC

Sofinnova Partners is rolling with the tide of large private equity interest in life sciences, but maintaining its independence through its sale of a minority stake to Apollo. The deal comes with up to €1 billion in capital commitments.

Sofinnova announced Monday that Apollo Global Management Inc. (NYSE:APO) acquired a 20% stake in the European VC firm through the issue of new shares at an undisclosed valuation. The deal includes commitments from Apollo to invest up to €1 billion ($1.04 billion) in future Sofinnova funds. Apollo is a major player in credit and real estate investments, with over $500 billion in assets under management...

BCIQ Company Profiles

Sofinnova Partners